Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP739585.RAfiBfC3H1u5YVcT0Ex3DnHjNMOXIguIuRb_do2ld6__M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP739585.RAfiBfC3H1u5YVcT0Ex3DnHjNMOXIguIuRb_do2ld6__M130_assertion type Assertion NP739585.RAfiBfC3H1u5YVcT0Ex3DnHjNMOXIguIuRb_do2ld6__M130_head.
- NP739585.RAfiBfC3H1u5YVcT0Ex3DnHjNMOXIguIuRb_do2ld6__M130_assertion description "[The aim of this study was to investigate the association of cystic fibrosis transmembrane conductance regulator (CFTR) and serine protease inhibitor Kazal type 1 (SPINK-1) gene mutations and monocyte chemoattractant protein 1 (MCP-1) -2518A/G polymorphism with acute pancreatitis (AP), acute recurrent pancreatitis (ARP), and chronic pancreatitis (CP), and to associate genetic backgrounds with clinical phenotype in these three conditions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739585.RAfiBfC3H1u5YVcT0Ex3DnHjNMOXIguIuRb_do2ld6__M130_provenance.
- NP739585.RAfiBfC3H1u5YVcT0Ex3DnHjNMOXIguIuRb_do2ld6__M130_assertion evidence source_evidence_literature NP739585.RAfiBfC3H1u5YVcT0Ex3DnHjNMOXIguIuRb_do2ld6__M130_provenance.
- NP739585.RAfiBfC3H1u5YVcT0Ex3DnHjNMOXIguIuRb_do2ld6__M130_assertion SIO_000772 19844201 NP739585.RAfiBfC3H1u5YVcT0Ex3DnHjNMOXIguIuRb_do2ld6__M130_provenance.
- NP739585.RAfiBfC3H1u5YVcT0Ex3DnHjNMOXIguIuRb_do2ld6__M130_assertion wasDerivedFrom befree-20140225 NP739585.RAfiBfC3H1u5YVcT0Ex3DnHjNMOXIguIuRb_do2ld6__M130_provenance.
- NP739585.RAfiBfC3H1u5YVcT0Ex3DnHjNMOXIguIuRb_do2ld6__M130_assertion wasGeneratedBy ECO_0000203 NP739585.RAfiBfC3H1u5YVcT0Ex3DnHjNMOXIguIuRb_do2ld6__M130_provenance.